Prospective Recurrent Pregnancy Loss Registry (NCT05989178)
Prospective Recurrent Pregnancy Loss (ProRPL) Registry
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this Registry is to prospectively collect data of Recurrent Pregnancy Loss (RPL) patients attending the specialized care centre at the BC Women's Hospital, in order to evaluate investigation practices, treatment options, and outcomes for this patient population over time.
Who can join: Review the eligibility criteria below.
Location: BC Women's Hospital & Health Centre — Vancouver, British Columbia
Age range: 15 Years to 49 Years
🧪 Interventions in This Study
- Data Registry (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- BC Women's Hospital & Health Centre — Vancouver, British Columbia
📞 Contact the Study Coordinator
Phone: (604) 875-2000
Email: mohamed.bedaiwy@cw.bc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Recurrent Pregnancy Loss
- Tender Loving Care for Recurrent Pregnancy Loss — Bethesda, Maryland
- Genomic Predictors of Recurrent Pregnancy Loss — Aurora, Colorado
Explore by condition: All Recurrent Pregnancy Loss clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.